🔎 Trials Near Me

Pradžia › Alkoholio vartojimo sutrikimas (AVS) › Merilendas

Alkoholio vartojimo sutrikimas (AVS) klinikiniai tyrimai Merilendas

24 tyrimai dėl Alkoholio vartojimo sutrikimas (AVS) ieško dalyvių vietose Merilendas.

Miestai Merilendas

Oficialus tyrimo tekstas (anglų kalba)

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

  • Behavioral Pharmacology Research Unit, Baltimore
Renkami dalyviai2/3 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07148843

Hepatic Lipid Metabolism-Alcohol Use Disorder

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07191561

Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05677321

Environment and Alcohol: A Pilot Study

  • National Institute on Drug Abuse, Baltimore
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 21 iki 100 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06860607

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

  • National Institute on Drug Abuse, Baltimore
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06676059

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06484075

A Study of Brenipatide in Participants With Alcohol Use Disorder

  • Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore
  • Maryland Treatment Centers - Avery Road Treatment Center, Rockville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07219953

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

  • Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore
  • Maryland Treatment Centers - Avery Road Treatment Center, Rockville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07219966

Spironolactone in Alcohol Use Disorder (SAUD)

  • National Institute on Drug Abuse, Baltimore
Renkami dalyviai1 fazė
Amžius nuo 21 iki 99 · Visoms lytims · Atnaujinta 2026-09-21 · NCT05807139

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06795581

Characterization Imaging Instruments in Alcoholics and Non-Alcoholics

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT02108080

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai4 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06269627

NIAAA Natural History Protocol

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-08-31 · NCT02231840

The Impact of Heavy Alcohol Use on Saliva and Oral Health

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-08-28 · NCT06684483

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

  • National Institute on Drug Abuse, Baltimore
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-24 · NCT06552741

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1 fazė
Amžius nuo 21 iki 70 · Visoms lytims · Atnaujinta 2026-08-17 · NCT07027839

Tirzepatide in MetALD

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai2 fazė
Amžius nuo 21 iki 100 · Visoms lytims · Atnaujinta 2026-08-12 · NCT07046819

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai1 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07559500

Behavioral and Functional Task Development, Implementation, and Testing

  • National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-30 · NCT02108054

COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study

  • NIAAA Section on Human Psychopharmacology, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-06-24 · NCT04391816

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

  • Johns Hopkins University School of Medicine, Baltimore
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-09 · NCT03845205

Cerebellar Involvement in Alcohol Use Disorder (AUD)

  • Johns Hopkins University School of Medicine, Baltimore
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 25 iki 55 · Visoms lytims · Atnaujinta 2026-05-11 · NCT05732207

A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects

  • Johns Hopkins Bayview Medical Center, Baltimore
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-03-31 · NCT05913752

Alcohol Research in HIV: Relapse Prevention

  • Johns Hopkins School of Medicine, Baltimore
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-18 · NCT05163301

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.